Calliditas is formerly owned by Sofinnova Partners, through Sofinnova Crossover Fund I, since 2020.

When did Sofinnova Partners acquire Calliditas?

Sofinnova Partners acquired Calliditas in 2020 and exited after 4 years.

Has Calliditas been sold?

Yes. Calliditas was exited in 2024 via Trade Sale.

Home/Companies/Biotech/Calliditas

Calliditas

Biotech·

Sweden·Exited 2024·Held 4yr

Calliditas is a healthcare / biotech company, headquartered in Sweden.

Entry

2020

Hold

4yr

Exit

2024

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQSweden

SectorHealthcare / Biotech

Swedish biopharma focused on orphan renal and hepatic indications, including Nefecon for IgA nephropathy. [2026-04-28] buyer + type: Asahi…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Crossover Fund I

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings